DK155686D0 - Parathyroidhormonholdigt praeparat - Google Patents
Parathyroidhormonholdigt praeparatInfo
- Publication number
- DK155686D0 DK155686D0 DK155686A DK155686A DK155686D0 DK 155686 D0 DK155686 D0 DK 155686D0 DK 155686 A DK155686 A DK 155686A DK 155686 A DK155686 A DK 155686A DK 155686 D0 DK155686 D0 DK 155686D0
- Authority
- DK
- Denmark
- Prior art keywords
- afflicted
- human
- parathyroidhormon
- containing preparation
- structual
- Prior art date
Links
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 102000003982 Parathyroid hormone Human genes 0.000 abstract 1
- 108090000445 Parathyroid hormone Proteins 0.000 abstract 1
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- -1 Vitamin D compound Chemical class 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 229940069978 calcium supplement Drugs 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000199 parathyroid hormone Substances 0.000 abstract 1
- 229960001319 parathyroid hormone Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72001885A | 1985-04-04 | 1985-04-04 | |
US72001885 | 1985-04-04 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK155686D0 true DK155686D0 (da) | 1986-04-04 |
DK155686A DK155686A (da) | 1986-10-05 |
DK172816B1 DK172816B1 (da) | 1999-08-02 |
Family
ID=24892318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198601556A DK172816B1 (da) | 1985-04-04 | 1986-04-04 | Farmaceutisk middel til forøgelse af knoglemasse |
Country Status (12)
Country | Link |
---|---|
US (1) | US4698328A (da) |
EP (1) | EP0197514B1 (da) |
JP (2) | JPH0772138B2 (da) |
AT (1) | ATE79271T1 (da) |
AU (1) | AU599905B2 (da) |
CA (1) | CA1288695C (da) |
DE (1) | DE3686343T2 (da) |
DK (1) | DK172816B1 (da) |
IE (1) | IE59620B1 (da) |
IL (1) | IL78342A (da) |
PH (1) | PH23720A (da) |
ZA (1) | ZA862510B (da) |
Families Citing this family (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4833125A (en) * | 1986-12-05 | 1989-05-23 | The General Hospital Corporation | Method of increasing bone mass |
DE3725319A1 (de) * | 1987-07-30 | 1989-02-09 | Biotechnolog Forschung Gmbh | Pth-modifikationen und therapeutische zusammensetzungen, die sie enthalten und daraus bestehen |
JPH0649655B2 (ja) * | 1987-11-12 | 1994-06-29 | シェリング・コーポレーション | Gm‐csfによる骨形成の促進 |
JPH07110809B2 (ja) * | 1987-11-18 | 1995-11-29 | 帝人株式会社 | 更年期障害の治療薬 |
IL89392A (en) * | 1988-03-23 | 1993-02-21 | Teva Pharmaceutical Ind Ltd Je | Compositions for the treatment of osteoporosis in humans comprising 24, 25-dihydroxy-vitamin d3 |
US5602116A (en) * | 1988-08-02 | 1997-02-11 | Bone Care International, Inc. | Method for treating and preventing secondary hyperparathyroidism |
US5104864A (en) * | 1988-08-02 | 1992-04-14 | Bone Care International, Inc. | Method for treating and preventing loss of bone mass |
CA1341408C (en) * | 1988-08-02 | 2002-12-10 | Charles W. Bishop | Method for treating and preventing loss of bone mass |
US4942036A (en) * | 1988-08-25 | 1990-07-17 | Blair Geho W | Therapy by vesicle delivery to the hydroxyapatite of bone |
DE4026146A1 (de) * | 1990-08-17 | 1992-02-20 | Biotechnolog Forschung Gmbh | Mittregionale pth fragmente in kombination mit 1,25(oh)(pfeil abwaerts)2(pfeil abwaerts)(pfeil hoch)d(pfeil hoch)(pfeil abwaerts)3(pfeil abwaerts) bewirken einen anabolen effekt (calciumeinbau) auf den knochen |
HUT64565A (en) * | 1990-12-13 | 1994-01-28 | Genentech Inc | Method for producing compounds and preparatives inhibiting resorption of bones |
US20040009958A1 (en) * | 1991-01-08 | 2004-01-15 | Bone Care International, Inc. | Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2 |
US6538037B2 (en) | 1991-01-08 | 2003-03-25 | Bone Care International, Inc. | Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2 |
US5693615A (en) * | 1991-06-05 | 1997-12-02 | The Procter & Gamble Company | Therapeutic compositions for osteoinduction |
WO1993011786A1 (en) * | 1991-12-17 | 1993-06-24 | Procter & Gamble Pharmaceuticals, Inc. | Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
US5382658A (en) * | 1992-04-03 | 1995-01-17 | Allelix Biopharmaceuticals Inc. | Stability-enhanced variants of parathyroid hormone |
CA2098639A1 (en) * | 1992-06-19 | 1993-12-20 | K. Anne Kronis | Bone stimulating, non-vasoactive parathyroid hormone variants |
US6509006B1 (en) | 1992-07-08 | 2003-01-21 | Inhale Therapeutic Systems, Inc. | Devices compositions and methods for the pulmonary delivery of aerosolized medicaments |
US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
KR100291620B1 (ko) | 1992-09-29 | 2001-10-24 | 추후제출 | 부갑상선호르몬의활성단편의폐를통한전달방법 |
US6024090A (en) | 1993-01-29 | 2000-02-15 | Aradigm Corporation | Method of treating a diabetic patient by aerosolized administration of insulin lispro |
US7448375B2 (en) | 1993-01-29 | 2008-11-11 | Aradigm Corporation | Method of treating diabetes mellitus in a patient |
TW303299B (da) * | 1993-07-22 | 1997-04-21 | Lilly Co Eli | |
US5763429A (en) | 1993-09-10 | 1998-06-09 | Bone Care International, Inc. | Method of treating prostatic diseases using active vitamin D analogues |
US5496801A (en) * | 1993-12-23 | 1996-03-05 | Allelix Biopharmaceuticals Inc. | Parathyroid hormone formulation |
CZ295827B6 (cs) | 1994-03-07 | 2005-11-16 | Nektar Therapeutics | Způsob aerosolizace dávky inzulinu, inzulinový přípravek a jeho použití |
US6051256A (en) * | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
US6376479B1 (en) | 1995-04-03 | 2002-04-23 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
US20040043971A1 (en) * | 1995-04-03 | 2004-03-04 | Bone Care International, Inc. | Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
US6242434B1 (en) | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
US20020183288A1 (en) * | 1995-04-03 | 2002-12-05 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
US5780014A (en) * | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
US6573256B2 (en) | 1996-12-30 | 2003-06-03 | Bone Care International, Inc. | Method of inhibiting angiogenesis using active vitamin D analogues |
US6566353B2 (en) | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
US6503893B2 (en) | 1996-12-30 | 2003-01-07 | Bone Care International, Inc. | Method of treating hyperproliferative diseases using active vitamin D analogues |
US20030203036A1 (en) | 2000-03-17 | 2003-10-30 | Gordon Marc S. | Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients |
AU750451B2 (en) | 1997-02-13 | 2002-07-18 | Bone Care International, Inc. | Targeted therapeutic delivery of vitamin D compounds |
US20030129194A1 (en) * | 1997-02-13 | 2003-07-10 | Bone Care International, Inc. | Targeted therapeutic delivery of vitamin D compounds |
SE9702401D0 (sv) | 1997-06-19 | 1997-06-19 | Astra Ab | Pharmaceutical use |
EP0891779A1 (de) * | 1997-06-19 | 1999-01-20 | Roche Diagnostics GmbH | Pharmazeutische Kombinationspräparate enthaltend Parathyroidhormon und Calcium- und/oder Phosphatverbindungen |
US6770623B1 (en) * | 1997-12-09 | 2004-08-03 | Eli Lilly And Company | Stabilized teriparatide solutions |
US20040033950A1 (en) * | 2000-09-26 | 2004-02-19 | Hock Janet M. | Method of increasing bone toughness and stiffness and reducing fractures |
DZ2873A1 (fr) * | 1998-08-19 | 2003-12-15 | Lilly Co Eli | Procédé pour augmenter la dureté et la rigidité osseuse. |
US6777388B1 (en) * | 1998-08-21 | 2004-08-17 | Clf Medical Technology Acceleration Program, Inc. | Leptin-related peptides |
EP1123401A1 (en) | 1998-10-22 | 2001-08-16 | The General Hospital Corporation | BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
EP1175444B1 (en) * | 1998-11-25 | 2008-01-23 | The General Hospital Corporation | Amino-terminal modified parathyroid hormone (pth) analogs |
DE69939275D1 (de) * | 1998-12-31 | 2008-09-18 | Gen Hospital Corp | Peptide, bestehend aus zwei funktionellen PTH-Domänen, die durch ein Linkermolekül verknüpft sind, und Derivate davon |
US7057012B1 (en) * | 1998-12-31 | 2006-06-06 | The General Hospital Corporation | PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
US6479474B2 (en) * | 1999-07-08 | 2002-11-12 | Wisconsin Alumni Research Foundation | Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis |
ATE309820T1 (de) * | 1999-09-20 | 2005-12-15 | Lilly Co Eli | Verwendung einer parathyroidhormone zur reduktion des krebsrisikos |
US7022815B1 (en) | 1999-09-29 | 2006-04-04 | The General Hospital Corporation | Polypeptide derivatives of parathyroid hormone (PTH) |
ATE412670T1 (de) | 1999-09-29 | 2008-11-15 | Gen Hospital Corp | Parathyroid hormon (pth) polypeptidderivate |
AU7734800A (en) * | 1999-09-29 | 2001-04-30 | General Hospital Corporation, The | Polypeptide derivatives of parathyroid hormone (pth) |
US7575761B2 (en) | 2000-06-30 | 2009-08-18 | Novartis Pharma Ag | Spray drying process control of drying kinetics |
JP2004504295A (ja) * | 2000-07-18 | 2004-02-12 | ボーン ケア インターナショナル インコーポレイテッド | 安定化1α−ヒドロキシビタミンD |
EP1339312B1 (en) * | 2000-10-10 | 2006-01-04 | Microchips, Inc. | Microchip reservoir devices using wireless transmission of power and data |
CA2454275C (en) * | 2001-07-23 | 2012-10-23 | The General Hospital Corporation | Conformationally constrained parathyroid hormone (pth) analogs |
US20030119771A1 (en) * | 2001-08-22 | 2003-06-26 | Rompaey Luc Van | Modulators of bone homeostasis identified in a high-throughput screen |
GB0216562D0 (en) | 2002-04-25 | 2002-08-28 | Bradford Particle Design Ltd | Particulate materials |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
WO2004022033A1 (en) * | 2002-09-04 | 2004-03-18 | Microchips, Inc. | Method and device for the controlled delivery of parathyroid hormone |
US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
US20040053895A1 (en) * | 2002-09-18 | 2004-03-18 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
EP1592434A4 (en) * | 2003-01-24 | 2009-07-01 | Gen Hospital Corp | PARATHORMONE ANALYSIS (PTH) WITH CONFORMATIONAL CONSTRAINTS WITH LACTAME BRIDGES |
WO2004093902A1 (en) * | 2003-03-19 | 2004-11-04 | The General Hospital Corporation | CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH α-HELIX STABILIZERS |
AU2004237438B2 (en) * | 2003-05-07 | 2011-01-20 | Osteologix A/S | Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions |
EP1653985A4 (en) | 2003-07-17 | 2009-08-05 | Gen Hospital Corp | CONSTRAINTS CONTAINING CONTAINING HORMONE PARATHYROID (PTH) ANALOGUES |
CA2534577A1 (en) * | 2003-08-06 | 2005-02-24 | Rhodia, Inc. | Method for promoting bone growth |
NZ545803A (en) * | 2003-09-19 | 2008-03-28 | Wisconsin Alumni Res Found | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hormone |
JP4815752B2 (ja) * | 2004-04-01 | 2011-11-16 | 味の素株式会社 | アミノ酸含有飲食品 |
EP1744683B1 (en) * | 2004-05-13 | 2016-03-16 | Alza Corporation | Apparatus and method for transdermal delivery of parathyroid hormone agents |
US7094775B2 (en) | 2004-06-30 | 2006-08-22 | Bone Care International, Llc | Method of treating breast cancer using a combination of vitamin D analogues and other agents |
US20080076975A1 (en) * | 2005-01-25 | 2008-03-27 | Microchips, Inc. | Method and implantable device with reservoir array for pre-clinical in vivo testing |
US7488316B2 (en) | 2005-01-25 | 2009-02-10 | Microchips, Inc. | Control of drug release by transient modification of local microenvironments |
CA2628945A1 (en) * | 2005-11-10 | 2007-05-24 | Board Of Control Of Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
JP2009545320A (ja) * | 2006-08-04 | 2009-12-24 | ザ ジェネラル ホスピタル コーポレイション | 副甲状腺ホルモン(pth)のポリペプチド誘導体 |
KR101661730B1 (ko) | 2007-08-01 | 2016-10-04 | 더 제너럴 하스피탈 코포레이션 | G―단백질 결합 수용체를 이용한 스크리닝 방법 및 관련 조성물 |
JP2013512688A (ja) | 2009-12-07 | 2013-04-18 | ミシガン テクノロジカル ユニバーシティ | クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法 |
WO2011143406A2 (en) | 2010-05-13 | 2011-11-17 | The General Hospital Corporation | Parathyroid hormone analogs and uses thereof |
WO2012111852A1 (ja) * | 2011-02-17 | 2012-08-23 | 帝人ファーマ株式会社 | 椎体骨折治療剤及びその評価方法 |
US9418415B2 (en) * | 2014-02-05 | 2016-08-16 | Shimadzu Corporation | Trabecular bone analyzer |
CN110236710A (zh) * | 2018-03-09 | 2019-09-17 | 中日友好医院 | 一种促进植骨材料在牙种植上颌窦外提升术后成骨的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3956260A (en) * | 1967-11-09 | 1976-05-11 | Ciba-Geigy Corporation | Hypocalcaemic peptides and processes for their manufacture |
US4241051A (en) * | 1977-11-04 | 1980-12-23 | Christie Robert B | Calcitonin |
JPS55139320A (en) * | 1979-04-16 | 1980-10-31 | Teijin Ltd | Bone metabolism regulator |
DE3243358A1 (de) * | 1982-11-24 | 1984-05-24 | Rolf Dieter Prof.Dr. 3004 Isernhagen Hesch | Synthetisches humanes (1-38) parathormon-fragment, verfahren zu seiner herstellung und die verwendung zur behandlung der osteoporose |
-
1986
- 1986-03-31 IL IL78342A patent/IL78342A/xx unknown
- 1986-04-03 AT AT86104562T patent/ATE79271T1/de not_active IP Right Cessation
- 1986-04-03 AU AU55616/86A patent/AU599905B2/en not_active Ceased
- 1986-04-03 EP EP86104562A patent/EP0197514B1/en not_active Expired - Lifetime
- 1986-04-03 DE DE8686104562T patent/DE3686343T2/de not_active Expired - Fee Related
- 1986-04-04 ZA ZA862510A patent/ZA862510B/xx unknown
- 1986-04-04 PH PH33623A patent/PH23720A/en unknown
- 1986-04-04 CA CA000505901A patent/CA1288695C/en not_active Expired - Lifetime
- 1986-04-04 DK DK198601556A patent/DK172816B1/da not_active IP Right Cessation
- 1986-04-04 IE IE89186A patent/IE59620B1/en not_active IP Right Cessation
- 1986-04-04 JP JP61078048A patent/JPH0772138B2/ja not_active Expired - Fee Related
- 1986-12-05 US US06/939,308 patent/US4698328A/en not_active Expired - Lifetime
-
1994
- 1994-12-05 JP JP6300817A patent/JP2531505B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK155686A (da) | 1986-10-05 |
DE3686343D1 (de) | 1992-09-17 |
IE59620B1 (en) | 1994-03-09 |
JPH07179358A (ja) | 1995-07-18 |
IL78342A (en) | 1991-06-10 |
IE860891L (en) | 1986-10-04 |
EP0197514B1 (en) | 1992-08-12 |
US4698328A (en) | 1987-10-06 |
EP0197514A1 (en) | 1986-10-15 |
AU5561686A (en) | 1986-10-09 |
JPS6233A (ja) | 1987-01-06 |
JP2531505B2 (ja) | 1996-09-04 |
AU599905B2 (en) | 1990-08-02 |
DE3686343T2 (de) | 1993-01-28 |
DK172816B1 (da) | 1999-08-02 |
JPH0772138B2 (ja) | 1995-08-02 |
ATE79271T1 (de) | 1992-08-15 |
ZA862510B (en) | 1986-11-26 |
CA1288695C (en) | 1991-09-10 |
PH23720A (en) | 1989-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK155686D0 (da) | Parathyroidhormonholdigt praeparat | |
ES2190244T3 (es) | Uso de la hormona paratiroidea constituida por una secuencia de aminoacidos 1-34 de la hormona paratiroidea humana para reducir el riesco de fracturas oseas vertebrales y no vertebrales. | |
IT1241996B (it) | Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione. | |
ES2055845T3 (es) | Composicion farmaceutica para el tratamiento de la osteoporosis. | |
NO942241L (da) | ||
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
IT1241997B (it) | Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione. | |
ATE75945T1 (de) | Pharmazeutische zubereitung zur behandlung des diabetes mellitus. | |
DK442287A (da) | Farmaceutisk praeparat indeholdende l-3,4-dihydroxyphenylalanin (l-dopa) som aktiv bestanddel og fremgangsmaade til fremstilling af et saadant praeparat | |
JPS55136229A (en) | Adjustment of bone metabolism in warm-blooded animal and drug for it | |
HK1029738A1 (en) | A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor. | |
ES2044947T4 (es) | Metodo para fabricar una composicion farmaceutica para el tratamiento de la osteoporosis y otras enfermedades oseas. | |
PT1089968E (pt) | Analogos de hormona tiroideia e metodos para a sua preparacao | |
SE9801495D0 (sv) | Protein formulationa | |
DE3166111D1 (en) | Pharmaceutical composition for healing inflammatory and/or degenerative and/or atrophic mucous membranes | |
TW360661B (en) | Superactive GRF analogs | |
KR920700224A (ko) | 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제 | |
IT1259140B (it) | Formulazioni farmaceutiche per la somministraziane orale di calcitonina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed | ||
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |
Country of ref document: DK |